Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020

Serological reactivity was analysed in plasma from 436 individuals with a history of disease compatible with COVID-19, including 256 who had been laboratory-confirmed with SARS-CoV-2 infection. Over 99% of laboratory-confirmed cases developed a measurable antibody response (254/256) and 88% harboure...

Descripción completa

Detalles Bibliográficos
Autores principales: Harvala, Heli, Mehew, Jennifer, Robb, Matthew L, Ijaz, Samreen, Dicks, Steven, Patel, Monika, Watkins, Nicholas, Simmonds, Peter, Brooks, Tim, Johnson, Rachel, Gopal, Robin, Roberts, David J, Zambon, Maria, Thomas, Stephen, MacLennan, Sheila, Estcourt, Lise, Brailsford, Su, Baklan, Hatice, Tettmar, Kate, Kellington, Jeremy, Sell, Joanne, Miflin, Gail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376844/
https://www.ncbi.nlm.nih.gov/pubmed/32700670
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376844/
https://www.ncbi.nlm.nih.gov/pubmed/32700670
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001260

Ejemplares similares